How Bad Was The Biotech Selloff Last Week?
February 04, 2018 at 17:30 PM EST
Biotech stocks got hit with a double whammy from concerns about high prices and disruption in healthcare from reform. But biotech investors made money last year and are still in the green for 2018 even after many stocks reported earnings.
